( CSE: DMED )
NatH2 Activities in:
Ontario
Collateral exposure:
Life sciences, NatH2 production tech

Company news

Grab your free 2025 Natural Hydrogen Investor Report and sign up for our biweekly newsletter!

    We respect your privacy. Unsubscribe at anytime.

    Latest NatH2 news

    More news